ATE508207T1 - Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens - Google Patents

Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens

Info

Publication number
ATE508207T1
ATE508207T1 AT07004186T AT07004186T ATE508207T1 AT E508207 T1 ATE508207 T1 AT E508207T1 AT 07004186 T AT07004186 T AT 07004186T AT 07004186 T AT07004186 T AT 07004186T AT E508207 T1 ATE508207 T1 AT E508207T1
Authority
AT
Austria
Prior art keywords
cells
detection
regulator
methylation analysis
gene
Prior art date
Application number
AT07004186T
Other languages
English (en)
Inventor
Jochen Huehn
Stefan Floess
Alf Hamann
Sven Olek
Udo Baron
Original Assignee
Charite Universitaetsmedizin
Epiontis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin, Epiontis Gmbh filed Critical Charite Universitaetsmedizin
Application granted granted Critical
Publication of ATE508207T1 publication Critical patent/ATE508207T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07004186T 2006-02-28 2007-02-28 Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens ATE508207T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77763106P 2006-02-28 2006-02-28

Publications (1)

Publication Number Publication Date
ATE508207T1 true ATE508207T1 (de) 2011-05-15

Family

ID=38039185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07004186T ATE508207T1 (de) 2006-02-28 2007-02-28 Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens

Country Status (8)

Country Link
US (2) US20070243161A1 (de)
EP (2) EP1826278A1 (de)
AT (1) ATE508207T1 (de)
DE (1) DE602007014278D1 (de)
DK (1) DK1826279T3 (de)
ES (1) ES2367012T3 (de)
PL (1) PL1826279T3 (de)
SI (1) SI1826279T1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2534139T3 (es) * 2004-12-02 2015-04-17 Epigenomics Ag Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el pronóstico de trastornos proliferativos de células de próstata
ATE508207T1 (de) * 2006-02-28 2011-05-15 Charite Universitaetsmedizin Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens
US20090317810A1 (en) * 2006-04-17 2009-12-24 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
US20090203011A1 (en) * 2007-01-19 2009-08-13 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
WO2009059327A2 (en) * 2007-11-02 2009-05-07 University Of Southern California (Usc) Compositions and methods comprising biomarkers of sperm quality, semen quality and fertility
US20110003292A1 (en) * 2007-12-11 2011-01-06 Dimo Dietrich Methods and nucleic acids for analyses of cell proliferative disorders
EP2281031A2 (de) * 2008-04-11 2011-02-09 University Of Southern California Verfahren und zusammensetzungen zur beschleunigung der erzeugung regulatorischer t-zellen ex vivo
EP2141245A1 (de) * 2008-07-03 2010-01-06 Ivana Türbachova DNS-Methylationsanalyse regulatorischer T-Zellen durch DNS-Methylationsanalyse der TSDR-Region des foxP3-Gens
WO2010007083A2 (en) * 2008-07-15 2010-01-21 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
US20100124747A1 (en) * 2008-11-03 2010-05-20 University Of Southern California Compositions and methods for diagnosis or prognosis of testicular cancer
US20170233807A1 (en) * 2008-12-16 2017-08-17 Epiontis Gmbh Epigenetic Markers for the Identification of Blood Sub-cells of Type 1
DK2199411T3 (en) 2008-12-16 2015-08-03 Epiontis Gmbh Epigenetic markers for the identification of CD3-positive T lymphocytes
EP2248913B1 (de) 2009-04-28 2016-10-05 Epiontis GmbH GNLY als epigenetischer Marker zur Identifikation von CD56-exprimierenden natürlichen Killerzellen
WO2011084333A1 (en) * 2009-12-16 2011-07-14 Hitachi Chemical Co., Ltd. Method for characterizing host immune function by ex vivo induction of offensive and defensive immune markers
EP2625288B1 (de) 2010-10-08 2016-05-25 Epiontis GmbH Verfahren zur bestimmung des überlebens eines krebspatienten auf basis der analyse der tumorinfiltration insgesamt
WO2012162660A2 (en) * 2011-05-25 2012-11-29 Brown University Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
US20140178348A1 (en) 2011-05-25 2014-06-26 The Regents Of The University Of California Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
WO2013135454A1 (en) * 2012-03-12 2013-09-19 Epiontis Gmbh Epigenetic marker for the identification of cd3cd4 positive t lymphocytes
GB201221133D0 (en) 2012-11-23 2013-01-09 Epiontis Gmbh Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes
WO2015006811A2 (en) * 2013-07-19 2015-01-22 The Walter And Eliza Hall Institute Of Medical Research Diagnostic methods
JP6709541B2 (ja) * 2014-10-17 2020-06-17 国立大学法人東北大学 大腸癌に対する薬物療法の感受性を予測する方法
DK3029150T3 (en) * 2014-12-05 2018-12-10 Epiontis Gmbh Epigenetic method for the identification of follicular T helper cells (TFH cells)
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法
GB201516972D0 (en) * 2015-09-25 2015-11-11 Epiontis Gmbh LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
GB201516975D0 (en) * 2015-09-25 2015-11-11 Epiontis Gmbh PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes
GB201516971D0 (en) * 2015-09-25 2015-11-11 Epiontis Gmbh MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
US20170253927A1 (en) * 2016-03-01 2017-09-07 Washington State University Heritable epigenetic modifications as markers of chemotherapy exposure
CN107301330A (zh) * 2017-06-02 2017-10-27 西安电子科技大学 一种利用全基因组数据挖掘甲基化模式的方法
CN107236805A (zh) * 2017-06-22 2017-10-10 深圳市龙岗区疾病预防控制中心(深圳市龙岗区卫生检验中心) 基于亚硫酸氢盐测序法的foxp3基因甲基化检测方法
WO2020007951A1 (en) * 2018-07-05 2020-01-09 Epiontis Gmbh Epigenetic method to detect and distinguish ipex and ipex-like syndromes, in particular in newborns
WO2022015860A1 (en) * 2020-07-15 2022-01-20 Rutgers, The State University Of New Jersey Biomarkers for identifying patients at high risk of progressing from barrett's esophagus to esophageal adenocarcinoma
CA3204918A1 (en) * 2021-01-14 2022-07-21 Chi T. VIET Methods for evaluation of early stage oral squamous cell carcinoma
DE102023112426A1 (de) * 2023-05-11 2024-11-14 Miltenyi Biotec B.V. & Co. KG Verfahren zur Optimierung von T-Zell - Produkten

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370685A2 (de) * 2000-04-06 2003-12-17 Epigenomics AG Diagnose von dns-reparatur assozierten krankheiten
US6858388B2 (en) * 2000-09-20 2005-02-22 Case Western Reserve University Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA
US7662549B1 (en) * 2000-10-27 2010-02-16 The University Of Southern California Methylation altered DNA sequences as markers associated with human cancer
JP2002171973A (ja) 2000-12-07 2002-06-18 Univ Tokyo Dnaメチル化パターンによる細胞の同定法
US7507542B2 (en) 2001-05-08 2009-03-24 Ucb Sa Method for regulating immune function using the FOXP3 protein
US20040072197A1 (en) * 2001-11-08 2004-04-15 Jones Peter A. Assay for the detection and quantitation of hemimethylation
WO2004050706A2 (en) 2002-12-03 2004-06-17 Medical Research Council Regulatory t-cells
US20060024676A1 (en) * 2003-04-14 2006-02-02 Karen Uhlmann Method of detecting epigenetic biomarkers by quantitative methyISNP analysis
GB0402051D0 (en) * 2004-01-29 2004-03-03 Metcalfe Su Fate determination in immunity
US7279281B2 (en) 2004-06-01 2007-10-09 The Regents Of The University Of Michigan Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
ATE508207T1 (de) * 2006-02-28 2011-05-15 Charite Universitaetsmedizin Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens

Also Published As

Publication number Publication date
DE602007014278D1 (de) 2011-06-16
PL1826279T3 (pl) 2011-11-30
EP1826278A1 (de) 2007-08-29
US20070269823A1 (en) 2007-11-22
US20070243161A1 (en) 2007-10-18
DK1826279T3 (da) 2011-09-05
ES2367012T3 (es) 2011-10-27
SI1826279T1 (sl) 2011-10-28
EP1826279B1 (de) 2011-05-04
US10876163B2 (en) 2020-12-29
EP1826279A1 (de) 2007-08-29

Similar Documents

Publication Publication Date Title
DE602007014278D1 (de) Nachweis und Qualitätskontrolle von Regulator-T-Zellen mittels DNA-Methylierungsanalyse des FoxP3-Gens
ATE509123T1 (de) Hochauflösende hochdurchsatz-hla-genotypisierung mittels klonaler sequenzierung
DK1871901T3 (da) Elitebegivenhed A5547-127 samt fremgangsmåder og sæt til identifikation af en sådan begivenhed i biologiske prøver
EP2043695B8 (de) Modelle für die bewertung von impfstoffen
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
NO20081127L (no) Vaksinering mot Dengue virusinfeksjon
MY173793A (en) New pcr sequencing method and use thereof in hla genotyping
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
CY1117574T1 (el) Αναλυση γονιδιωματικων κλασματων με χρηση των αριθμων πολυμορφισμων
EP4574995A3 (de) Verfahren und kits zum nachweis des methylierungsstatus
SI2504454T1 (sl) Elitni dogodek EE-GM3 in metode in kompleti za identifikacijo takega dogodka v bioloških vzorcih
CA2816976A1 (en) Optogenetic control of reward-related behaviors
GB201121917D0 (en) Genetic analysis to determine ingredient efficacy
WO2009134944A3 (en) Methods of determining the health status of an individual
NZ590832A (en) Genetic variants for schizophrenia risk assessment
WO2010069499A3 (en) Epigenetic markers for the identification of cd3 positive t-lymphocytes
EP2173467A4 (de) Verfahren und vorrichtung unter verwendung eines elektrischen felds für verbesserte biologische assays
PT2121963E (pt) Métodos para identificar uma estirpe isolada a partir de uma amostra clínica ao nível da espécie e/ou subespécie
MY185926A (en) Ssr markers for plants and uses thereof
MX2008013397A (es) Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos.
BRPI0908734A2 (pt) Métodos para a identificação de dna genômico em uma amostra e para a indentificação de polimorfismos, e, kit
EP2075341A4 (de) Verfahren zur untersuchung, bestimmung oder bewertung mittels genexpressionsanalyse
ATE534738T1 (de) Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen
WO2012015165A3 (ko) 광 투과성 열 블록을 포함하는 pcr 장치
WO2012135620A3 (en) Molecular gram stain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1826279

Country of ref document: EP